PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in PolyPid Ltd. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −3 vs. Q2 2021
- Shares held
- 1.53M
- −112.7K (−6.9%) vs. Q2 2021
- Total value
- $11.9M
- −$2.97M (−20.0%) vs. Q2 2021
- New holders
- 0
- 7 more added
- Sold out
- 3
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PYPD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $16.7M |
| Q1 2026 | 19 | $13.7M |
| Q4 2025 | 19 | $13.0M |
| Q3 2025 | 16 | $9.45M |
| Q2 2025 | 15 | $10.2M |
| Q1 2025 | 13 | $6.90M |
| Q4 2024 | 14 | $7.50M |
| Q3 2024 | 12 | $6.64M |
| Q2 2024 | 9 | $5.18M |
| Q1 2024 | 8 | $5.13M |
| Q4 2023 | 5 | $79.6K |
| Q3 2023 | 4 | $93.2K |
| Q2 2023 | 14 | $155.2K |
| Q1 2023 | 11 | $147.8K |
| Q4 2022 | 13 | $265.3K |
| Q3 2022 | 18 | $566.0K |
| Q2 2022 | 27 | $4.95M |
| Q1 2022 | 27 | $6.10M |
| Q4 2021 | 27 | $8.71M |
| Q3 2021 | 19 | $11.9M |
| Q2 2021 | 22 | $14.9M |
| Q1 2021 | 20 | $14.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding PolyPid Ltd.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 471,414 | $3.67M | 0.01% | −133,968−22.1% | Reduced |
| Moore Capital Management, LP | 279,942 | $2.18M | 0.04% | −2,035−0.7% | Reduced |
| UBS Group AG | 204,555 | $1.59M | 0.00% | +50,395+32.7% | Added |
| Silverarc Capital Management, LLC | 183,230 | $1.43M | 0.83% | +28,664+18.5% | Added |
| Victory Capital Management Inc | 111,617 | $868.0K | 0.00% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 100,000 | $778.0K | 0.00% | 00.0% | Unchanged |
| Meitav Dash Investments Ltd | 31,500 | $246.0K | 0.00% | +17,000+117.2% | Added |
| Raymond James Financial Services Advisors, Inc. | 24,361 | $190.0K | 0.00% | +4,545+22.9% | Added |
| Invesco Ltd. | 21,088 | $164.0K | 0.00% | −3,031−12.6% | Reduced |
| JPMorgan Chase & Co | 20,830 | $162.0K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 18,194 | $142.0K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 16,351 | $127.0K | 0.00% | +406+2.5% | Added |
| Geode Capital Management, LLC | 12,545 | $97.0K | 0.00% | +1,364+12.2% | Added |
| Cresset Asset Management, LLC | 11,719 | $91.0K | 0.00% | 00.0% | Unchanged |
| 1623 Capital LLC | 11,627 | $90.0K | 0.04% | 00.0% | Unchanged |
| Morgan Stanley | 3,000 | $24.0K | 0.00% | −494−14.1% | Reduced |
| BlackRock Inc. | 3,091 | $24.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 2,053 | $16.0K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2,115 | $16.0K | 0.00% | +500+31.0% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −56,530−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −19,189−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −327−100.0% | Sold out |